Satovsky Asset Management’s Alpha Tau Medical DRTS Stock Holding History

Satovsky Asset Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$288K	Sell	40,706 -12,900	-24%	-$91.1K	0.05%	55
2025 Q4	$265K	Hold	53,606	–	–	0.05%	59
2025 Q3	$242K	Hold	53,606	–	–	0.05%	53
2025 Q2	$167K	Hold	53,606	–	–	0.04%	64
2025 Q1	$135K	Hold	53,606	–	–	0.03%	55
2024 Q4	$166K	Hold	53,606	–	–	0.04%	53
2024 Q3	$128K	Hold	53,606	–	–	0.03%	55
2024 Q2	$136K	Buy	53,606 +5,012	+10%	+$12.8K	0.03%	51
2024 Q1	$143K	Sell	48,594 -9,836	-17%	-$30.2K	0.04%	49
2023 Q4	$176K	Buy	+58,430	New	+$188K	0.05%	48

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Satovsky Asset Management's DRTS Position: Q1 2026 in Review

Satovsky Asset Management reduced its Alpha Tau Medical (DRTS) stake by 24% in Q1 2026, selling an estimated $91.1K and leaving 40,706 shares worth $288K. The position accounts for 0.05% of the portfolio, ranked #55.

Satovsky Asset Management first reported a position in DRTS in Q4 2023 and has held it in 10 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Satovsky Asset Management held 40,706 shares of Alpha Tau Medical worth $288K as of Q1 2026.
Satovsky Asset Management sold 12,900 Alpha Tau Medical shares in Q1 2026, an estimated $91.1K.
Alpha Tau Medical made up 0.05% of Satovsky Asset Management's portfolio in Q1 2026, its #55 holding.
Satovsky Asset Management first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 10 quarters since.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.